These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 35909613)
21. Analysis of interactions of clinical mutants of catalase-peroxidase (KatG) responsible for isoniazid resistance in Mycobacterium tuberculosis with derivatives of isoniazid. Unissa AN; Doss C GP; Kumar T; Swathi S; Lakshmi AR; Hanna LE J Glob Antimicrob Resist; 2017 Dec; 11():57-67. PubMed ID: 28743650 [TBL] [Abstract][Full Text] [Related]
22. [Effect of carboxymethylated chitosan on apoptosis and expression of brain derived neurotrophic factor and glial cell line derived neurotrophic factor in oxidative stress induced Schwann cells in vitro]. He B; Tao H; Liu S Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Dec; 28(12):1530-5. PubMed ID: 25826901 [TBL] [Abstract][Full Text] [Related]
23. The katG mRNA of Mycobacterium tuberculosis and Mycobacterium smegmatis is processed at its 5' end and is stabilized by both a polypurine sequence and translation initiation. Sala C; Forti F; Magnoni F; Ghisotti D BMC Mol Biol; 2008 Apr; 9():33. PubMed ID: 18394163 [TBL] [Abstract][Full Text] [Related]
24. Site-directed mutagenesis and virulence assessment of the katG gene of Mycobacterium intracellulare. Marklund BI; Mahenthiralingam E; Stokes RW Mol Microbiol; 1998 Aug; 29(4):999-1008. PubMed ID: 9767568 [TBL] [Abstract][Full Text] [Related]
25. Isoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: catalase, peroxidase, and INH-NADH adduct formation activities. Cade CE; Dlouhy AC; Medzihradszky KF; Salas-Castillo SP; Ghiladi RA Protein Sci; 2010 Mar; 19(3):458-74. PubMed ID: 20054829 [TBL] [Abstract][Full Text] [Related]
26. Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Rouse DA; Li Z; Bai GH; Morris SL Antimicrob Agents Chemother; 1995 Nov; 39(11):2472-7. PubMed ID: 8585728 [TBL] [Abstract][Full Text] [Related]
27. Differential Sensitivity of Mycobacteria to Isoniazid Is Related to Differences in KatG-Mediated Enzymatic Activation of the Drug. Reingewertz TH; Meyer T; McIntosh F; Sullivan J; Meir M; Chang YF; Behr MA; Barkan D Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767723 [TBL] [Abstract][Full Text] [Related]
28. The mycobacterial LysR-type regulator OxyS responds to oxidative stress and negatively regulates expression of the catalase-peroxidase gene. Li Y; He ZG PLoS One; 2012; 7(1):e30186. PubMed ID: 22272299 [TBL] [Abstract][Full Text] [Related]
29. De Novo Emergence of Genetically Resistant Mutants of Mycobacterium tuberculosis from the Persistence Phase Cells Formed against Antituberculosis Drugs In Vitro. Sebastian J; Swaminath S; Nair RR; Jakkala K; Pradhan A; Ajitkumar P Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895008 [TBL] [Abstract][Full Text] [Related]
30. Three-dimensional model and molecular mechanism of Mycobacterium tuberculosis catalase-peroxidase (KatG) and isoniazid-resistant KatG mutants. Mo L; Zhang W; Wang J; Weng XH; Chen S; Shao LY; Pang MY; Chen ZW Microb Drug Resist; 2004; 10(4):269-79. PubMed ID: 15650370 [TBL] [Abstract][Full Text] [Related]
31. Cultured Schwann cells assemble normal-appearing basal lamina only when they ensheathe axons. Clark MB; Bunge MB Dev Biol; 1989 Jun; 133(2):393-404. PubMed ID: 2659405 [TBL] [Abstract][Full Text] [Related]
32. Distinct H Wan F; Feng X; Yin J; Gao H Front Microbiol; 2021; 12():626874. PubMed ID: 34025596 [TBL] [Abstract][Full Text] [Related]
33. Significance of catalase-peroxidase (KatG) mutations in mediating isoniazid resistance in clinical strains of Mycobacterium tuberculosis. Unissa AN; Doss C GP; Kumar T; Sukumar S; Lakshmi AR; Hanna LE J Glob Antimicrob Resist; 2018 Dec; 15():111-120. PubMed ID: 29990547 [TBL] [Abstract][Full Text] [Related]
34. Roles of the three Mycobacterium smegmatis katG genes for peroxide detoxification and isoniazid susceptibility. Iwao Y; Nakata N Microbiol Immunol; 2018 Mar; 62(3):158-167. PubMed ID: 29345334 [TBL] [Abstract][Full Text] [Related]
35. Detection of a point mutation associated with high-level isoniazid resistance in Mycobacterium tuberculosis by using real-time PCR technology with 3'-minor groove binder-DNA probes. van Doorn HR; Claas EC; Templeton KE; van der Zanden AG; te Koppele Vije A; de Jong MD; Dankert J; Kuijper EJ J Clin Microbiol; 2003 Oct; 41(10):4630-5. PubMed ID: 14532194 [TBL] [Abstract][Full Text] [Related]
36. Site-directed mutagenesis of the katG gene of Mycobacterium tuberculosis: effects on catalase-peroxidase activities and isoniazid resistance. Rouse DA; DeVito JA; Li Z; Byer H; Morris SL Mol Microbiol; 1996 Nov; 22(3):583-92. PubMed ID: 8939440 [TBL] [Abstract][Full Text] [Related]
37. Schwann cell plasminogen activator is regulated by neurons. Clark MB; Zeheb R; White TK; Bunge RP Glia; 1991; 4(5):514-28. PubMed ID: 1834568 [TBL] [Abstract][Full Text] [Related]
38. A novel mechanism of growth phase-dependent tolerance to isoniazid in mycobacteria. Niki M; Niki M; Tateishi Y; Ozeki Y; Kirikae T; Lewin A; Inoue Y; Matsumoto M; Dahl JL; Ogura H; Kobayashi K; Matsumoto S J Biol Chem; 2012 Aug; 287(33):27743-52. PubMed ID: 22648414 [TBL] [Abstract][Full Text] [Related]